BRCA1 & BRCA2 gene analysis_ONCO

BRCA1 & BRCA2 Gene Analysis (ONCO)

Understand Your Hereditary Cancer Risk with Advanced Genetic Testing

BRCA1 & BRCA2 Gene Analysis (ONCO) is a specialized genetic test that detects inherited mutations in the BRCA1 and BRCA2 genes. These mutations significantly increase the risk of developing hereditary breast, ovarian, prostate, pancreatic, and certain other cancers. Early identification enables personalized cancer prevention, early detection, and treatment planning.

Why is this test important?

• Identifies inherited BRCA1 and BRCA2 gene mutations
• Assesses hereditary cancer risk
• Helps guide personalized screening and preventive strategies
• Supports treatment decisions, including targeted therapies
• Enables genetic counseling and family risk assessment

Who should consider this test?

• Individuals with a family history of breast, ovarian, pancreatic, or prostate cancer
• Patients diagnosed with breast or ovarian cancer at a young age
• Individuals with multiple relatives affected by related cancers
• Families with known BRCA mutations
• Those seeking hereditary cancer risk evaluation

Sample Required

• Peripheral Blood (EDTA)

Benefits

• Early identification of hereditary cancer risk
• Personalized prevention and surveillance plans
• Informed treatment options and precision oncology
• Risk assessment for family members
• Supports proactive healthcare decisions

Advanced Genetic Testing for Early Detection, Better Prevention, and Personalized Cancer Care.